Optinose (OPTN) Stock Statistics & Valuation Metrics

Optinose has a market cap or net worth of $97.22M. The enterprise value is $152.41M.

Optinose has 41,436,000 shares outstanding. The number of shares has decreased by -2.65% in one year.

Optinose’s return on equity (ROE) is 0.53 and return on invested capital (ROIC) is -17.42%.

The current PE Ratio of Optinose is -3.15. Optinose’s PEG ratio is <0.01.

In the last 12 months, Optinose had revenue of 78.23M and earned -21.54M in profits. Earnings per share was -2.12.

In the last 12 months, operating cash flow was -22.86M and capital expenditures -50.00K, giving a free cash flow of -22.70M billion.

Optinose pays an annual dividend of ―, resulting in a dividend yield of ―

Optinose upcoming earnings date is Aug 7, 2025, TBA Not Confirmed.

Optinose as a current ratio of 0.77, with Debt / Equity ratio of -207.29%

In the past 12 months, Optinose has paid 0.00 in taxes.

Optinose EV to EBITDA ratio is -93.76, with an EV/FCF ratio of -2.51.

Optinose has $72.93M in cash and marketable securities with $127.20M in debt, giving a net cash position of $54.27M billion.

Gross margin is 90.53%, with operating margin of -20.86%, and net profit margin of -27.54%.

The average price target for Optinose is $9.00, which is 11.43% higher than the current price. The consensus rating is Hold